Evidence map›Paper›PMID 40493675›Full record

ArticlePLoS pathogens2025

Plasmodium falciparum expresses fewer var genes at lower levels during asymptomatic dry season infections than clinical malaria cases.

Sukai Ceesay, Martin Kampmann, Lasse Votborg-Novél, Helle Smedegaard Hansson, Rasmus Weisel Jensen, Manuela Carrasquilla, Hamidou Cisse, Louise Turner, Usama Dabbas, Christina Ntalla and 9 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Integrative genomics ofbioRxiv : the preprint server for biology · 2026
    Article
  5. Serological evidence of high exposure toMalariaWorld journal · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sukai CeesayMax-Planck-Institute for Infection Biology, Berlin, Germany.
Martin KampmannMax-Planck-Institute for Infection Biology, Berlin, Germany.
Lasse Votborg-NovélMax-Planck-Institute for Infection Biology, Berlin, Germany.
Helle Smedegaard HanssonCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.
Rasmus Weisel JensenCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.
Manuela CarrasquillaMax-Planck-Institute for Infection Biology, Berlin, Germany.
Hamidou CisseMali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Louise TurnerCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.
Usama DabbasMax-Planck-Institute for Infection Biology, Berlin, Germany.
Christina NtallaMax-Planck-Institute for Infection Biology, Berlin, Germany.
Silke BandermannMax-Planck-Institute for Infection Biology, Berlin, Germany.
Safiatou DoumboMali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Didier DoumtabeMali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Aissata OngoibaMali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Kassoum KayentaoMali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Boubacar TraoreMali International Centre of Excellence in Research, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Peter D CromptonLaboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, Division of Intramural Research, National Institutes of Health, Rockville, Maryland, United States of America.
Thomas LavstsenCentre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Righospitalet, Copenhagen, Denmark.
Silvia PortugalMax-Planck-Institute for Infection Biology, Berlin, Germany.ORCID 0000-0003-4567-9101

Funding

National Institute of Allergy and Infectious DiseasesNational Institutes of Health (PDC)NHLBI NIH HHS
6 · The paper itself

Abstract

In seasonal transmission areas, clinical malaria occurs during the wet season when mosquitoes are present, while in the dry season, malaria transmission is interrupted and clinical cases are rare. In Mali, Plasmodium falciparum can persist in low parasitaemic asymptomatic individuals through the six-month dry season and shows circulation of more developed parasite stages compared to clinical malaria cases, indicative of reduced cytoadhesion of infected erythrocytes. How prolonged circulation of infected erythrocytes is achieved remains unknown. Here, we explored var gene expression in subclinical infections and clinical malaria cases of Malian children, collected during the dry and wet seasons. We sequenced expressed var DBLα-tags, used bioinformatic tools to predict their domain composition, binding phenotype and upstream sequence type; and determined their relationship to seasonality and clinical presentation. We found that parasites of asymptomatic infections expressed fewer var genes, with a larger proportion of var transcripts attributed to one or a few vars. In contrast, clinical cases exhibited expression of many var genes at lower proportions. We found that parasites of asymptomatic carriers expressed a mixture of CD36- and EPCR-binding PfEMP1, which changed over time. We confirmed that vars encoding CD36-binding PfEMP1 dominated in non-severe malaria cases, and found no significant difference in expressed var types between dry and wet seasons. Asymptomatic carriers were older, had higher titers of anti-P. falciparum antibodies, and broader reactivity to PfEMP1, suggesting that host immunity was the main determinant limiting var transcript variation in asymptomatic carriers. However, qRT-PCR analyses also indicated higher total var transcript levels in malaria cases compared to asymptomatic carriers, suggesting that in addition to the parasite's switching and the host's immune selection of expressed var genes, parasites able to sustain long-term infections may be poised for reduced PfEMP1 expression.

Indexed as

Malaria, FalciparumPlasmodium falciparumProtozoan ProteinsAsymptomatic InfectionsChildChild, PreschoolFemaleHumansInfantMaleMaliSeasonserythrocyte membrane protein 1, Plasmodium falciparumProtozoan Proteins

Identifiers

PMID40493675
PMCPMC12151486

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.